PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
65.08%
Positive growth while CRK shows revenue decline. John Neff would investigate competitive advantages.
8.18%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
113.05%
Positive growth while CRK shows decline. John Neff would investigate competitive advantages.
29.06%
Margin expansion while CRK shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-32.71%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
-39.41%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-38.80%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-21.83%
Both companies reducing total costs. Martin Whitman would check industry trends.
-5.26%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-0.49%
Both companies reducing D&A. Martin Whitman would check industry patterns.
276.02%
EBITDA growth while CRK declines. John Neff would investigate advantages.
154.85%
EBITDA margin growth while CRK declines. John Neff would investigate advantages.
348.34%
Operating income growth exceeding 1.5x CRK's 127.72%. David Dodd would verify competitive advantages.
250.44%
Operating margin growth exceeding 1.5x CRK's 159.03%. David Dodd would verify competitive advantages.
9.09%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
257.60%
Pre-tax income growth while CRK declines. John Neff would investigate advantages.
195.47%
Pre-tax margin growth while CRK declines. John Neff would investigate advantages.
1067.86%
Tax expense growth while CRK reduces burden. John Neff would investigate differences.
220.00%
Net income growth while CRK declines. John Neff would investigate advantages.
172.69%
Net margin growth while CRK declines. John Neff would investigate advantages.
219.88%
EPS growth while CRK declines. John Neff would investigate advantages.
216.96%
Diluted EPS growth while CRK declines. John Neff would investigate advantages.
-0.18%
Share count reduction while CRK shows 0.10% change. Joel Greenblatt would examine strategy.
0.03%
Diluted share reduction exceeding 1.5x CRK's 0.10%. David Dodd would verify capital allocation.